That's a wrap.
Market opens Friday, Nov 13 at 9:30 AM ET
Follow / Funds
John Paulson
Sold more than boughtFiled Aug 14, 2026 for holdings on Jun 30, 2026, 45 days after the quarter ended. The next one is due by Nov 14, 2026.
Stocks reported
$2.58B
as of Jun 30, 2026
Positions
8
all shown below
Top 10 stocks
100.0%
of the money in stocks
Options
None
none reported
| # | Holding | Weight |
|---|---|---|
| 1 | MDGLMadrigal Pharmaceuticals Trimmed −3.8% | 27.9% |
| 2 | PPTAPerpetua Resources | 26.1% |
| 3 | AAMIAcadian Asset Management Trimmed −24.5% | 16.2% |
| 4 | BHCBausch Health Cos | 14.0% |
| 5 | THMInternational Tower Hill Mines Added +4.9% | 8.1% |
| 6 | NGNovagold Resources | 6.3% |
| 7 | THRYThryv | 1.3% |
| 8 | GOOGLAlphabet New | 0.1% |
Values at quarter end, not today's prices.
| Quarter | Filed | Stocks | Filing |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $2.58B | EDGAR |
| Q1 2026 | May 15, 2026 | $3.11B | EDGAR |
| Q4 2025 | Feb 17, 2026 | $3.26B | EDGAR |
| Q3 2025 | Nov 14, 2025 | $2.97B | EDGAR |
| Q2 2025 | Aug 14, 2025 | $2.01B | EDGAR |
| Q1 2025 | May 15, 2025 | $1.75B | EDGAR |
| Q4 2024 | Feb 14, 2025 | $1.65B | EDGAR |
| Q3 2024 | Nov 14, 2024 | $1.43B | EDGAR |
| Q2 2024 | Aug 14, 2024 | $1.35B | EDGAR |
| Q1 2024 | May 15, 2024 | $1.45B | EDGAR |
| Q4 2023 | Feb 14, 2024 | $1.11B | EDGAR |
| Q3 2023 | Nov 14, 2023 | $1.12B | EDGAR |
| Q2 2023 | Aug 14, 2023 | $1.02B | EDGAR |
| Q1 2023 | May 15, 2023 | $1.20B | EDGAR |
| Q4 2022 | Feb 14, 2023 | $1.11B | EDGAR |
| Q3 2022 | Nov 14, 2022 | $1.37B | EDGAR |
| Q2 2022 | Aug 15, 2022 | $2.03B | EDGAR |
| Q1 2022 | May 16, 2022 | $3.25B | EDGAR |
| Q4 2021 | Feb 14, 2022 | $3.24B | EDGAR |
| Q3 2021 | Nov 15, 2021 | $3.51B | EDGAR |
| Q2 2021 | Aug 16, 2021 | $4.18B | EDGAR |
| Q1 2021 | May 17, 2021 | $4.35B | EDGAR |
| Q4 2020 | Feb 16, 2021 | $3.85B | EDGAR |
| Q3 2020 | Nov 16, 2020 | $3.21B | EDGAR |
| Q2 2020 | Aug 14, 2020 | $3.13B | EDGAR |
| Q1 2020 | May 15, 2020 | $2.62B | EDGAR |
| Q4 2019 | Feb 14, 2020 | $4.63B | EDGAR |
| Q3 2019 | Nov 14, 2019 | $4.87B | EDGAR |
| Q2 2019 | Aug 14, 2019 | $5.60B | EDGAR |
| Q1 2019 | May 15, 2019 * | $9.21B | EDGAR |
| Q4 2018 | Feb 14, 2019 | $4.17B | EDGAR |
| Q3 2018 | Nov 14, 2018 | $5.32B | EDGAR |
| Q2 2018 | Aug 14, 2018 | $4.85B | EDGAR |
| Q1 2018 | May 15, 2018 | $4.57B | EDGAR |
| Q4 2017 | Feb 14, 2018 | $5.12B | EDGAR |
| Q3 2017 | Nov 14, 2017 | $5.53B | EDGAR |
| Q2 2017 | Aug 14, 2017 * | $7.30B | EDGAR |
| Q1 2017 | May 15, 2017 | $7.46B | EDGAR |
| Q4 2016 | Feb 14, 2017 | $7.74B | EDGAR |
| Q3 2016 | Nov 14, 2016 | $9.11B | EDGAR |
| Q2 2016 | Aug 15, 2016 | $9.71B | EDGAR |
| Q1 2016 | May 16, 2016 | $13.4B | EDGAR |
| Q4 2015 | Feb 16, 2016 | $16.7B | EDGAR |
| Q3 2015 | Nov 16, 2015 | $19.3B | EDGAR |
| Q2 2015 | Aug 14, 2015 | $21.7B | EDGAR |
| Q1 2015 | May 15, 2015 | $19.6B | EDGAR |
| Q4 2014 | Feb 17, 2015 | $19.4B | EDGAR |
| Q3 2014 | Nov 14, 2014 | $24.1B | EDGAR |
| Q2 2014 | Aug 14, 2014 | $23.1B | EDGAR |
| Q1 2014 | May 15, 2014 | $20.4B | EDGAR |
| Q4 2013 | Feb 14, 2014 | $20.3B | EDGAR |
| Q3 2013 | Nov 14, 2013 | $15.5B | EDGAR |
| Q2 2013 | Aug 14, 2013 | $14.2B | EDGAR |
They usually file 45 days after the quarter ends. * amended later.
NewAmicus Therapeutic<0.1% of the bookAddedTHM41.8% more sharesAddedTHRY94.2% more sharesTrimmedMDGL18.5% fewer sharesExitedSOLSwas 2.1%
Holdings as of Mar 31 (Q1 2026), filed 45 days later (the report at the SEC)
NewJuniper Networks Inc0.5% of the bookNewGOOG0.1% of the bookAddedPPTA30.6% more sharesAddedBHC24.0% more sharesTrimmedMDGL0.5% fewer sharesExitedIntra-Cellular Therapies Incwas 0.2%
Holdings as of Jun 30 (Q2 2025), filed 45 days later (the report at the SEC)
NewHoneywell Intl Inc2.4% of the bookNewIntra-Cellular Therapies Inc0.2% of the bookAddedMDGL2.8% more sharesAddedTHM9.4% more sharesExitedGOOGLwas 0.1%
Holdings as of Mar 31 (Q1 2025), filed 45 days later (the report at the SEC)
About Paulson & Co.: Family office concentrated in gold miners and a few special situations. A 13F is up to 45 days old when filed and shows long US stock positions only. Not investment advice.
Copying Paulson & Co.'s 13F filings from Feb 2020 would have turned $10,000 into $22,127, less than the S&P 500 did.
A test before costs and taxes, not a real account. Companies that were later delisted or bought out are skipped, which flatters it. See the full copy test, year by year →